# Niels Jongs

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/niels-jongs/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,826 |
| Field | Diabetes Treatment and Management |
| h-index | 31 |
| i10-index | 48 |
| Last Known Institution | University Medical Center Groningen |
| OpenAlex ID | https://openalex.org/A5018701033 |
| ORCID iD | 0000-0002-0882-3656 |
| Works | 140 |

## Researcher papers

- [Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-major-adverse-kidney-and-cardiovascular-events-in/)
- [A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy](https://scholariq.org/papers/a-pre-specified-analysis-of-the-dapa-ckd-trial-demonstrates-the-effects-of/)
- [Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-urinary-albumin-excretion-in-patients-with-chronic/)
- [Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-the-rate-of-decline-in-kidney-function-in-patients/)
- [Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial](https://scholariq.org/papers/albuminuria-lowering-effect-of-dapagliflozin-eplerenone-and-their-combination-in/)
- [Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease](https://scholariq.org/papers/effect-of-dapagliflozin-on-clinical-outcomes-in-patients-with-chronic-kidney/)
- [Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-sglt2-inhibitors-with-and-without-glucagon-like-peptide-1/)
- [Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-mortality-in-patients-with-chronic-kidney-disease-a/)
- [Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure](https://scholariq.org/papers/effects-of-dapagliflozin-in-patients-with-kidney-disease-with-and-without-heart/)
- [Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial](https://scholariq.org/papers/semaglutide-in-patients-with-overweight-or-obesity-and-chronic-kidney-disease/)
- [Finerenone in Persons with Chronic Kidney Disease without Diabetes](https://scholariq.org/papers/finerenone-in-persons-with-chronic-kidney-disease-without-diabetes/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Researcher university

- [University Medical Center Groningen](https://scholariq.org/institutions/university-medical-center-groningen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.